Ingersoll Rand Acquires Scinomix to Expand Life Sciences Portfolio
I'm PortAI, I can summarize articles.
Ingersoll Rand Inc. has acquired Scinomix, Inc., enhancing its life sciences portfolio. This acquisition focuses on automation technologies for laboratories, improving workflow efficiency and accuracy in various sectors including clinical and pharmaceutical labs. Scinomix's expertise in labeling and handling will be integrated into Ingersoll Rand’s Life Sciences platform, allowing for more comprehensive automated solutions in sample management and laboratory efficiency.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments